Alto Neuroscience, Inc. (ANRO)

22.39 +0.03 (+0.13%) USD  |  NYSE  |  Mar 18, 15:32
More

Alto Neuroscience Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for ANRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Oramed Pharmaceuticals, Inc. Upgrade
Replimune Group, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade